Planetary Herbals, Vitex 500mg Full Spectrum Std 0.5% Agnusides, 120 ct
UPC Code: 021078104247
Planetary Herbals Full Spectrum Vitex Extract combines a standardized extract of chaste tree berries, concentrated to 0.5% agnusides, with whole berries. Vitex modifies the effect of the hypothalamus and pituitary glands. This helps regulate and balance female hormone production. Combining the extract with the whole berry ensures that the full spectrum of vitex compounds are included.
Packaging
120 tabs
Suggested Use
1 tablet twice daily. Take throughout the month, except during menstruation.
Ingredients
Calcium - 45 mg
Chaste Tree Berry - 375 mg
Chaste Tree Berry Extract (0.5%) Yielding minimum 625 mcg Agnusides - 125 mg
Other Ingredients: dibasic calcium phosphate, silicified microcrystalline cellulose, stearic acid, modified cellulose gum, and colloidal silicon dioxide.
About Planetary Herbals
Planetary Herbals (formerly Planetary Formulas) have been developed by expert herbalists, focusing predominantly on the thousands of years of experience of Ayurvedic and traditional Chinese herbalism, the hundreds of years of experience of Western herbal practitioners, and the more than 30 years of experience of our professional herbalists. Planetary Herbals offers the best of classic herbal traditions, integrating herbal formulas used continuously for literally hundreds of thousands of years, with the latest finding of scientific research. The Planetary Herbals philosophy encompasses much more than herbal magic bullets. Each product is designed to promote health, not just make people feel better.
Safety
Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.
Disclaimer
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.